齐屹科技(01739.HK)批准采纳2021年受限制股份单位计划
齐屹科技(01739.HK)公布,已批准采纳2021年受限制股份单位计划。2021年受限制股份单位计划旨在吸引、保留及激励集团的最优人才及高级管理层,并透过向该等人士提供获得公司股份及成功所带来的专有权益的机会以提升公司的价值,从而将彼等的权益与公司的业绩挂钩。
董事会可於2021年受限制股份单位计划生效期间,不时确定将受限制股份单位归属或入账之任何归属准则或条件。信托人须持有已奖励之股份,直至该等股份根据受限制股份单位之条款归属予相关选定参与者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.